MP4 August 16, 2017 6:40 pm Boston Business Journal Report: Gains Follow Alzheimer's Drug Managing editor Don Seiffert joins necn to discuss his story, “Biogen gains $1B in value after Goldman Sachs touts Alzheimer’s drug.” US & World Videos 1:32 Amber Alert for 2 NH girls canceled, father in custody 2:53 Latest on Lewiston, Maine shootings 2:01 Local researchers looking to turn plastic into fuel 1:45 Gov. Healey to sign bottle ban order for state agencies 2:41 Leominster students return to school after floods
